Learn from the industry’s cell therapy clinical trials

With only a small number of approved regenerative therapies on the market and many clinical trials currently being completed on a small scale, the opportunities to learn from completed clinical trials are slim. 

However with larger clinical investigations currently underway in pharma and biotechs, there is an opportunity to learn from their successes and failures to adopt industry best practice. 

REGEN 2013 explored the pioneering clinical trials in the field in order to provide guidance on the design and execution of your own clinical trial.  

The meeting help attendees to understand the clinical strategies for some of the most promising regenerative medicines and enabled you to optimize your practices and push your therapy through to patients faster. 

Designed to give you access to the acquired knowledge and experience of the industry, REGEN 2013 provided a unique opportunity for you to identify common flaws in clinical trial designs in order to design the most effective clinical strategy for your product. 

Attending the meeting meant understanding what investors really need to see to validate investment. Attendees found out how you can demonstrate cost effectiveness to the satisfaction of payors and ultimately achieve reimbursement for your product. 

DOWNLOAD THE BROCHURE

Top 10 reasons for attending REGEN 2013?

  1. Explore the success and challenges of pharma’s ongoing clinical trials to gain practical guidance for your own programme with presentations from Athersys, Baxter and Celgene
     
  2. Find out why many clinical trials fail in this space and identify some of the key flaws and failure modes for regenerative medicine products with Gregory Bonfiglio and Lee Buckler
     
  3. Optimize the likelihood of  gaining reimbursement for your product by finding out how you can design your clinical trial to prove efficacy to the satisfaction of payors with Blue Cross Blue Shield Association
     
  4. Increase your chance of gaining investment from large pharma with a keynote presentation from Neusentis on what large pharma are looking for in their partners
     
  5. Learn how you can design your clinical trials with most effective biomakers and endpoints to achieve regulatory approval and reimbursement with Juventas Therapeutics and Janssen
     
  6. Understand how to obtain payor approval by meeting with venture capitalist firms active in this space who will be highlighting the critical considerations for reimbursement and investment
     
  7. Understand what you can do prior to approval to enable uptake by attending an interactive workshop led by Pfizer, offering you 1:1 advice and guidance
     
  8. Expand your network and get practical advice on how to overcome your challenges from joining heads of regenerative medicine and cell therapy from across the industry in both our speed networking session and round table discussions
     
  9. Identify the most exciting new programs for cell therapies with the potential to expand your own pipeline with University of Texas’ groundbreaking work on patient-specific pluripotent stem cells
     
  10. Attend a meeting which is solely focused on the clinical challenges for cell based regenerative medicines to have your specific questions answered by thought leaders from leading pharma, biotechs and research institutes  

DOWNLOAD THE BROCHURE

Who should attend? 

REGEN 2013: Clinical Trials & Reimbursement - the only meeting dedicated to providing you with the practical guidance and advice you need to perfect your clinical trial structure. If you are working in clinical development or looking to enter the clinic with your cell based regenerative product then this meeting addressed the major challenges you need to overcome to reach the market. 

This means the meeting was for: 

  • Heads and Directors of regenerative medicine or cell therapy groups looking to translate their work into the clinical setting or further their current clinical investigations 
  • Academics and professionals involved in clinical studies and investigations or interested in translating their current work into the clinic 
  • Clinicians involved in the execution of clinical trials within regenerative medicine and cell therapy who are looking to make contacts within the field 
  • Technology specialists seeking to highlight novel platforms, assays and equipment and to network with regenerative medicine developers to license or sell their products
  • Consultants looking to keep up-to-date with the advances in the clinical space and make contacts in the field of regenerative medicine 
  • Business development professionals and venture capitalist firms assessing pipeline investment opportunities and looking for potential collaborations 

Learn from the experience of your peers and make sure you have the knowledge you need to ensure your clinical trial is optimal for proving safety and efficacy for your cell based regenerative medicine.  

What's next? 

Download the brochure to see what will be covered at the meeting

Don't forget to check out the Interactive Pre-Conference Workshops

Choose your package - see prices and discounts here (with significant discounts for non-profit institutions)